Design and rationale for the Myocardial Stem Cell Administration After Acute Myocardial Infarction (MYSTAR) Study: A multicenter, prospective, randomized, single-blind trial comparing early and late intracoronary or combined (percutaneous intramyocardial and intracoronary) administration of nonselected autologous bone marrow cells to patients after acute myocardial infarction
- 17 January 2007
- journal article
- research article
- Published by Elsevier BV in American Heart Journal
- Vol. 153 (2), 212.e1-212.e7
- https://doi.org/10.1016/j.ahj.2006.10.027
Abstract
No abstract availableThis publication has 30 references indexed in Scilit:
- Autologous skeletal myoblast transplantation for severe postinfarction left ventricular dysfunctionJournal of the American College of Cardiology, 2003
- Stem Cells to Repair the HeartCirculation Research, 2003
- Derivation and Potential Applications of Human Embryonic Stem CellsCirculation Research, 2002
- Stem Cells — Scientific, Medical, and Political IssuesNew England Journal of Medicine, 2002
- Skeletal Muscle Stem Cells Do Not Transdifferentiate Into Cardiomyocytes After Cardiac GraftingJournal of Molecular and Cellular Cardiology, 2002
- Bone marrow cells regenerate infarcted myocardiumNature, 2001
- Neovascularization of ischemic myocardium by human bone-marrow–derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac functionNature Medicine, 2001
- Therapeutic Potential of Ex Vivo Expanded Endothelial Progenitor Cells for Myocardial IschemiaCirculation, 2001
- Bone Marrow Origin of Endothelial Progenitor Cells Responsible for Postnatal Vasculogenesis in Physiological and Pathological NeovascularizationCirculation Research, 1999
- Regenerating functional myocardium: Improved performance after skeletal myoblast transplantationNature Medicine, 1998